Business · 29/06/2020
FDA Establishes Public Docket to Solicit Comments on Codeine Use in Children Under 12
The FDA is seeking public input on the use of codeine for pain relief in children under 12, particularly after genetic testing for the CYP2D6 enzyme, which affects how the body metabolizes codeine.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →